Collaborative Network PSI already partners with government and private sector actors to curb fake medicines. This established ecosystem presents an opportunity to introduce joint threat intelligence solutions, data sharing platforms, and co-branded training for member manufacturers. A joint go-to-market with PSI could accelerate adoption across their network and global footprint.

Member Network Value As a nonprofit trade association of security directors, PSI forms a ready-made channel to reach decision-makers at pharmaceutical manufacturers. There is potential to offer enterprise-grade, PSI-branded threat intelligence portals, API feeds, and secure alert dissemination tailored to member needs. This could enable scalable, low-friction deployment across multiple companies.

Digital Threat Coverage PSI's focus on online threats and the Pharma Fraud report shows a priority on online counterfeit and fraud risk. There is demand for end-to-end digital risk protection, including monitoring, detection, takedowns, and remediation across digital channels. A managed service offering or platform with online threat monitoring could be co-sold with existing partners.

Cloud Platform Fit The tech stack indicates adoption of cloud and modern web delivery; PSI could benefit from a secure, cloud-based threat intelligence platform with scalable data ingestion and dashboards. Propose offering an API-enabled intelligence feed, secure data sharing among members, and analytics that align with public health protection objectives.

Lean Operations With a small team and revenue in the lower mid-range, PSI likely relies on partnerships and external providers. This creates an opportunity to offer plug-and-play, managed security services or white-label solutions that require minimal internal resources to implement, plus training and enablement resources for member companies.